Altimmune Inc.
ALT | NASDAQ
$3.27
+$0.02 (+0.62%)
At close: Sep 21, 2026, 4:00 PM ET
$3.30
+$0.03 (+0.92%)
Pre-market:
Sep 22, 2026, 6:06 AM ET
Market Data
Market Cap $635.93M
Enterprise Value $345.35M
Beta 0.18
Average Volume 4.1M
Shares Outstanding (Diluted) 185.44M
Shares Change YoY 127.6%
Institutional Ownership 55.74%
Exchange NASDAQ
ISIN US02155H2004
Price Performance
Price Change 1M 5.1%
Price Change 3M 12.4%
Price Change 6M -1.2%
Price Change YTD -6.8%
Price Change 1Y -17.4%
Price Change 3Y 25.3%
Price Change 5Y -78.2%
1M CAGR (ann.) 6.2%
1Y CAGR (ann.) -15.5%
5Y CAGR (ann.) -27.7%
All-Time CAGR -32.8%
Valuation
PE Ratio -4.19
Forward PE N/A
PEG Ratio -0.09
Forward PEG -0.45
PS Ratio 20,513.87
Forward PS 24.70
PB Ratio 1.34
P/FCF Ratio -8.31
P/Adj. FCF Ratio -6.97
P/OCF Ratio -7.98
EV/Sales 11,140.42
EV/EBIT -3.91
EV/EBITDA -3.92
EV/FCF -4.51
Earnings Yield -23.9%
FCF Yield -12.0%
Adj. FCF Yield -14.3%
Financial Health
Net Cash $291.58M
Total Debt $35.75M
Cash & Short-Term Investments $326.32M
Total Assets $527.21M
Current Ratio 26.78
Quick Ratio 26.78
Debt / Equity Ratio 0.08
Debt / EBITDA -0.41
Debt / FCF -0.47
OCF / Debt -2.14
Interest Coverage -28.34
Altman Z-Score 5.53
Piotroski F-Score 4
Margins & Profitability
Gross Profit Margin -48306.4%
Operating Profit Margin -323306.5%
EBITDA Margin -298787.1%
Net Profit Margin -296000.0%
FCF Margin -246974.2%
Adj. FCF Margin -294267.7%
SBC / Revenue 47293.6%
SBC Impact (per share) -19.1%
Returns
Return on Assets -17.4%
Return on Equity -31.4%
Return on Invested Capital -19.5%
Return on Capital Employed -19.5%
Return on Tangible Assets -17.4%
Historical Growth (CAGR)
Revenue CAGR 3Y -123.3%
Revenue CAGR 5Y -65.4%
Revenue CAGR 10Y -40.5%
EPS CAGR 3Y 35.2%
EPS CAGR 5Y 22.4%
EPS CAGR 10Y -64.1%
FCF CAGR 3Y -3.3%
FCF CAGR 5Y -3.1%
FCF CAGR 10Y -65.6%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 15
EPS Growth Next 3Y 3.9%
Revenue Growth Next 3Y 933.3%
Earnings Date Nov 4, 2026
EPS Estimate (next Q) -$0.14
EPS Growth Est (next Q) -33.3%
Revenue Est (next Q) $1.75K
Revenue Growth Est (next Q) -65.0%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $6.25
Price Target Upside 91.1%
Cash Flow
Operating Cash Flow $-76.51M
Free Cash Flow $-76.56M
Adj. Free Cash Flow $-91.22M
FCF Per Share -$0.41
OCF Per Share -$0.41
OCF/S Ratio -246800.0%
Income Statement
Revenue $31K
Gross Profit $-33.61M
Operating Income $-100.23M
EBITDA $-88.15M
Net Income $-91.76M
EPS (Diluted) -$0.78
Revenue / Employee $543.86
Profit / Employee $-1.61M
Employees 57
Add to Watchlist
Select watchlists to add or remove ALT